<DOC>
	<DOCNO>NCT01267214</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Hyalgan proximal tibial osteotomy treatment knee osteoarthritis patient . Normally , OA patient treat osteotomy treated SYSADOA operation , even though cartilage 's completely loss , osteotomy plus HA injection provide benefit patient osteotomy alone .</brief_summary>
	<brief_title>The Efficacy Safety Intraarticular Sodium Hyaluronate ( Hyalgan ) After Proximal Tibial Osteotomy Treatment Knee Osteoarthritis Patients</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Patients 35 65 year primary knee OA malalignment 2 . Mild moderate OA grade II III severity KellgrenLawrence scale require treatment osteotomy 3 . Malalignment exceed 15 degree ( + , ) 4 . Pain walking ( 15 ) â‰¥ 40 mm . 5 . Range motion &gt; 90 degree 6 . Evidence adequate contraceptive method woman childbearing age 1 . Previous surgery affect knee 2 . Previous intraarticular intervention within last 3 month ( eg . Steroid , anaesthetic , Sodium hyaluronate ) 3 . Oral SYSADOA treatment ( chondroitin , glucosamine , diacerein ) within 2 month prior study start 4 . Known suspected infection affect joint 5 . Painful knee condition due another cause chondral lesion , Sudeck 's atrophy , intraarticular neoplasm , pigment villonodular synovitis , chondromatosis 6 . Poor general health condition would make regular hospital attendance difficult 7 . Ascertained hypersensitivity component use study ( eg . Hyaluronic acid , diclofenac , morphine , omeprazole paracetamol ) 8 . Hypersensitivity avian protein 9 . Ongoing previous participation clinical study within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>